Published in J Clin Oncol on November 20, 2005
Tarceva Italian Lung Optimization tRial (TAILOR) | NCT00637910
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies | NCT00703625
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol (2009) 4.95
Treatment of advanced non small cell lung cancer. J Thorac Dis (2011) 1.32
Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study. BMC Cancer (2007) 0.99
Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer. Br J Clin Pharmacol (2010) 0.97
Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2010) 0.95
Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy. BMC Cancer (2007) 0.93
Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose. Cancer Sci (2015) 0.92
Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma. Br J Cancer (2008) 0.90
A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer. Br J Cancer (2010) 0.90
Personalising docetaxel and G-CSF schedules in cancer patients by a clinically validated computational model. Br J Cancer (2012) 0.86
The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis. Br J Cancer (2009) 0.85
Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials. Int J Clin Oncol (2011) 0.84
A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours. Br J Cancer (2013) 0.84
First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study. Br J Cancer (2008) 0.84
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer. Cancer Chemother Pharmacol (2010) 0.83
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party. Br J Cancer (2007) 0.81
Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer. Curr Oncol (2014) 0.81
Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck. BMC Cancer (2013) 0.80
Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis. Cancer Res Treat (2012) 0.80
A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies. Cancer Chemother Pharmacol (2008) 0.79
Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma. World J Gastroenterol (2015) 0.79
A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer. Invest New Drugs (2013) 0.78
A Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer. Case Rep Oncol (2014) 0.78
Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic disease. Invest New Drugs (2008) 0.77
Docetaxel monotherapy as second-line treatment for pretreated advanced non-small cell lung cancer patients. Korean J Intern Med (2007) 0.77
Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy. Int J Nanomedicine (2012) 0.76
Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis. Lung Cancer (Auckl) (2010) 0.75
Weekly low-dose docetaxel for salvage chemotherapy in pretreated elderly or poor performance status patients with non-small cell lung cancer. J Korean Med Sci (2008) 0.75
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer. PLoS One (2016) 0.75
Refining the treatment of advanced nonsmall cell lung cancer. Lung Cancer (Auckl) (2010) 0.75
Consolidation chwemotherapy after concurrent chemoradiotherapy vs. chemoradiotherapy alone for locally advanced unresectable stage III non-small-cell lung cancer: A meta-analysis. Mol Clin Oncol (2016) 0.75
A Novel Metabolite from Aspergillus ochraceus JGI 25 Showing Cytotoxicity to Hela Cells. Indian J Pharm Sci (2013) 0.75
Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study. Thorac Cancer (2015) 0.75
International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med (2012) 5.42
Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. Dtsch Arztebl Int (2014) 2.47
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia. J Clin Oncol (2009) 2.23
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease. J Thorac Oncol (2015) 1.92
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. Blood (2010) 1.56
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer. Mod Pathol (2012) 1.50
Topotecan/cisplatin compared with cisplatin/etoposide as first-line treatment for patients with extensive disease small-cell lung cancer: final results of a randomized phase III trial. J Thorac Oncol (2012) 1.45
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG). Blood (2013) 1.33
Thoracic ultrasound for diagnosing pulmonary embolism: a prospective multicenter study of 352 patients. Chest (2005) 1.27
Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration (2003) 1.03
Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis. Cancer Epidemiol Biomarkers Prev (2009) 0.93
Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany. Oncol Res Treat (2014) 0.90
Radiological findings, pulmonary function and dyspnea in underground coal miners. Respiration (2005) 0.90
Multicenter randomized trial for stage IIIB/IV non-small-cell lung cancer using every-3-week versus weekly paclitaxel/carboplatin. Clin Lung Cancer (2006) 0.86
Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program. J Thorac Oncol (2008) 0.86
Influence of NaCl 0.9% Infusion during Plasmapheresis on IgG Content in Plasma. Transfus Med Hemother (2010) 0.85
A multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma. Clin Lung Cancer (2003) 0.85
Interferon-alphacon-1 treatment of three patients with severe glucocorticoid-dependent asthma. Effect on disease control and systemic glucocorticosteroid dose. Respiration (2005) 0.85
Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial. J Thorac Oncol (2011) 0.84
Transthoracic sonography in comparison to multislice computed tomography in detection of peripheral pulmonary embolism. Lung (2010) 0.83
Clinical integrated ultrasound of the thorax including causes of shock in nontraumatic critically ill patients. A practical approach. Ultrasound Med Biol (2012) 0.82
Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study. J Occup Med Toxicol (2008) 0.82
Computed tomography imaging in pulmonary embolism--the other side of the medal. Respiration (2004) 0.80
Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial. BMC Cancer (2010) 0.78
Ultrasound performs better than radiographs. Thorax (2010) 0.78
[Current trends in pneumology 2002 -- Part 1]. Med Klin (Munich) (2003) 0.77
Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life. Lung Cancer (2004) 0.77
Interferon-gamma-1b: therapeutic option in advanced idiopathic pulmonary fibrosis? Respiration (2005) 0.77
Analysis for prognostic factors of 60-day mortality: evaluation of an irinotecan-based phase III trial performed in the first-line treatment of metastatic colorectal cancer. Clin Colorectal Cancer (2011) 0.77
Phase II trial of gemcitabine/irinotecan in refractory or relapsed small-cell lung cancer. Clin Lung Cancer (2005) 0.77
A phase II study of weekly docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer. J Thorac Oncol (2009) 0.76
A giant neuroendocrine tumor of the thymus gland causing superior vena cava syndrome. Gen Thorac Cardiovasc Surg (2012) 0.76
Response. Chest (2013) 0.75
Pulmonary fibrosis of the upper lobes after lung transplantation is associated with selective CD8+ T lymphocyte expansion. AJR Am J Roentgenol (2005) 0.75
Interferons and their application in lung diseases. Chest (2003) 0.75
Relevance of subpleural consolidations in chest ultrasound. Chest (2009) 0.75
Pemetrexed in the treatment of malignant mesothelioma: results from an expanded access program in Germany. Respir Med (2009) 0.75
Survival of patients in clinical stages I-IIIb of non-small-cell lung cancer treated with radiation therapy alone. Results of a population-based study in Southern Saxony-Anhalt. Strahlenther Onkol (2004) 0.75
[Diagnosis of pulmonary artery embolism. Reply]. Dtsch Med Wochenschr (2002) 0.75
[Therapy for non-small-cell lung carcinoma (NSCLC) in stage IV]. Onkologie (2006) 0.75
Clinical benefit in NSCLC: advanced-stage patients require symptom-improving palliation. Experiences from the 'Iressa' expanded access program. Onkologie (2005) 0.75
[Current developments and perspectives in targeted therapies]. Onkologie (2010) 0.75
Randomized, multicenter, open-label phase II study of gemcitabine plus single-dose versus split-dose carboplatin in the treatment of patients with advanced-stage non-small-cell lung cancer. Clin Lung Cancer (2006) 0.75
A relative survival model for clustered responses. Biom J (2008) 0.75
Computed tomography for diagnosis and grading of dust-induced occupational lung disease. Curr Opin Pulm Med (2008) 0.75
The impact of workload on hygiene compliance in nursing. Br J Nurs (2010) 0.75